• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙加泰罗尼亚地区1型糖尿病患者的临床特征以及血糖和心血管危险因素的控制程度

Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain).

作者信息

Gimenez-Perez Gabriel, Franch-Nadal Josep, Ortega Emilio, Mata-Cases Manel, Goday Albert, Real Jordi, Rodriguez Angel, Vlacho Bogdan, Mauricio Dídac

机构信息

Endocrinology Unit, Department of Medicine, Hospital General de Granollers, 08402 Granollers, Spain.

DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.

出版信息

J Clin Med. 2021 Apr 6;10(7):1536. doi: 10.3390/jcm10071536.

DOI:10.3390/jcm10071536
PMID:33917523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8038775/
Abstract

BACKGROUND

This study aims to evaluate the clinical characteristics, complications, degree of glycemic control, and cardiovascular risk factor control in patients with type 1 diabetes in Catalonia (Northwest of Spain).

METHODS

Cross-sectional study using a database including clinical, laboratory, and treatment data. Patients with an ICD10 diagnosis of type 1 diabetes were included, excluding those treated with glucose-lowering agents other than insulin, or treated only with basal insulin two years after diagnosis.

RESULTS

15,008 patients were analysed. Median IQR age was 42 (31-53) years, diabetes duration 11.8 (6.8-16.0) years, 56.5% men. Median (IQR) HbA1c was 7.9% (7.1-8.8). Microvascular complications were present in 24.4% of patients, 43.6% in those with a diabetes duration >19 years. In presence of known cardiovascular disease 69.3% of patients showed an LDL-C concentration >70 mg/dL, 37% had a systolic blood pressure >135 mmHg and 22.4% were smokers.

CONCLUSIONS

This study provides a reliable snapshot about the clinical situation of a large population of patients with T1D in Catalonia, which is similar to that of other western areas. The lack of adequate control of cardiovascular risk factors in a significant proportion of patients with cardiovascular disease deserves a more detailed analysis and urges the need for improvement strategies.

摘要

背景

本研究旨在评估西班牙西北部加泰罗尼亚地区1型糖尿病患者的临床特征、并发症、血糖控制程度以及心血管危险因素控制情况。

方法

采用横断面研究,使用包含临床、实验室和治疗数据的数据库。纳入ICD10诊断为1型糖尿病的患者,排除诊断两年后使用除胰岛素以外的降糖药物治疗或仅使用基础胰岛素治疗的患者。

结果

分析了15,008例患者。年龄中位数(四分位间距)为42(31 - 53)岁,糖尿病病程为11.8(6.8 - 16.0)年,男性占56.5%。糖化血红蛋白(HbA1c)中位数(四分位间距)为7.9%(7.1 - 8.8)。24.4%的患者存在微血管并发症,糖尿病病程>19年的患者中这一比例为43.6%。在已知患有心血管疾病的患者中,69.3%的患者低密度脂蛋白胆固醇(LDL-C)浓度>70mg/dL,37%的患者收缩压>135mmHg,22.4%的患者吸烟。

结论

本研究提供了加泰罗尼亚地区大量1型糖尿病患者临床状况的可靠概况,与其他西部地区相似。相当一部分心血管疾病患者的心血管危险因素缺乏充分控制,值得进行更详细的分析,并迫切需要改进策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68d/8038775/fc272c552844/jcm-10-01536-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68d/8038775/511290932eb8/jcm-10-01536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68d/8038775/fc272c552844/jcm-10-01536-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68d/8038775/511290932eb8/jcm-10-01536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68d/8038775/fc272c552844/jcm-10-01536-g002.jpg

相似文献

1
Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain).西班牙加泰罗尼亚地区1型糖尿病患者的临床特征以及血糖和心血管危险因素的控制程度
J Clin Med. 2021 Apr 6;10(7):1536. doi: 10.3390/jcm10071536.
2
Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.速效胰岛素类似物与常规人胰岛素对比:糖尿病患者血糖控制效果的荟萃分析
Diabetes Ther. 2020 Mar;11(3):573-584. doi: 10.1007/s13300-019-00732-w. Epub 2019 Dec 23.
3
Heart Disease and Diabetes心脏病与糖尿病
4
Metabolic memory: Evolving concepts.代谢记忆:不断发展的概念。
J Diabetes. 2018 Mar;10(3):186-187. doi: 10.1111/1753-0407.12622. Epub 2017 Dec 11.
5
[Control of blood pressure in a population of patients with hypertension and in a subgroup with hypertension and diabetes: relationship with characteristics of the health care center and the community].[高血压患者群体以及高血压合并糖尿病亚组的血压控制:与医疗保健中心及社区特征的关系]
Aten Primaria. 2001 Oct 15;28(6):373-80. doi: 10.1016/s0212-6567(01)70397-6.
6
Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.肯尼亚县级医院糖尿病门诊 2 型糖尿病门诊患者心血管危险因素控制的充分性。
BMC Endocr Disord. 2017 Dec 1;17(1):73. doi: 10.1186/s12902-017-0223-1.
7
[The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].[1型糖尿病患者的代谢综合征。与心血管危险因素及心血管疾病发病率的关联]
Herz. 2004 Aug;29(5):463-9. doi: 10.1007/s00059-004-2606-0.
8
Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.女性在 2 型糖尿病和心血管疾病风险因素的控制方面比男性差:来自意大利糖尿病学会 MIND.IT 研究组的结果。
Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):235-41. doi: 10.1016/j.numecd.2011.12.003. Epub 2012 Mar 6.
9
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis.2型糖尿病患者起始基础胰岛素治疗后的血糖控制:一项初级保健数据库分析
Diabetes Metab Syndr Obes. 2015 Jan 14;8:45-8. doi: 10.2147/DMSO.S76855. eCollection 2015.
10
Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes.普兰林肽作为基础胰岛素辅助药物对2型糖尿病患者心血管风险标志物的影响。
Curr Med Res Opin. 2008 Jan;24(1):79-85. doi: 10.1185/030079908x253537.

引用本文的文献

1
Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis.1型糖尿病女性的心血管疾病:一项叙述性综述及基于人群队列分析的见解
Cardiovasc Diabetol. 2025 May 21;24(1):217. doi: 10.1186/s12933-025-02791-9.
2
Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1.德国和法国成人 1 型糖尿病一级预防中心血管危险因素及其管理的性别不平等:来自 DPV 和 SFDT1 的研究结果。
Cardiovasc Diabetol. 2024 Sep 16;23(1):342. doi: 10.1186/s12933-024-02419-4.
3

本文引用的文献

1
Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record database.1 型糖尿病患者血糖控制达标与未达标患者的差异:美国电子健康记录数据库中超过 30000 例患者的真实世界研究。
Diabetes Obes Metab. 2020 Apr;22(4):622-630. doi: 10.1111/dom.13937. Epub 2019 Dec 26.
2
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31.
3
Physical activity patterns in type 1 diabetes in Spain: The SED1 study.
西班牙1型糖尿病患者的身体活动模式:SED1研究。
BMC Sports Sci Med Rehabil. 2023 Jul 26;15(1):92. doi: 10.1186/s13102-023-00695-3.
4
Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia.1 型糖尿病患者首次心血管事件的流行病学:加泰罗尼亚基于人群的回顾性队列研究。
Cardiovasc Diabetol. 2023 Jul 14;22(1):179. doi: 10.1186/s12933-023-01917-1.
5
The Bittersweet Beat: Diabetes Complications.苦乐参半的节奏:糖尿病并发症
J Clin Med. 2023 Jun 13;12(12):4018. doi: 10.3390/jcm12124018.
6
Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia.加泰罗尼亚地区 1 型糖尿病患者大型基于人群队列中的肥胖症及相关合并症。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1015614. doi: 10.3389/fendo.2022.1015614. eCollection 2022.
Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
美国 1 型糖尿病成年患者中严重低血糖和糖尿病酮症酸中毒的发生率以及按年龄和血糖控制分层的微血管并发症的患病率:一项真实世界研究。
Diabetes Care. 2019 Dec;42(12):2220-2227. doi: 10.2337/dc19-0830. Epub 2019 Sep 23.
4
Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.全球儿童和青少年 1 型糖尿病发病率、患病率和死亡率的估计值:国际糖尿病联盟糖尿病地图集,第 9 版的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107842. doi: 10.1016/j.diabres.2019.107842. Epub 2019 Sep 10.
5
The number of adults with incident type 1 diabetes phenotype in Iceland is half the number in children - A population based study.冰岛成人发病 1 型糖尿病表型患者人数为儿童的一半——一项基于人群的研究。
Diabetes Res Clin Pract. 2019 May;151:224-230. doi: 10.1016/j.diabres.2019.04.023. Epub 2019 Apr 18.
6
Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases.德国成年1型糖尿病患者的患者及疾病特征:对糖尿病患者数据中心(DPV)和糖尿病干预及并发症研究(DIVE)数据库的分析
Ther Adv Endocrinol Metab. 2019 Feb 28;10:2042018819830867. doi: 10.1177/2042018819830867. eCollection 2019.
7
Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.1 型糖尿病视网膜病变的危险因素:DCCT/EDIC 研究。
Diabetes Care. 2019 May;42(5):875-882. doi: 10.2337/dc18-2308. Epub 2019 Mar 4.
8
Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.1 型糖尿病患者死亡率和心血管结局的相对预后重要性及最佳危险因素水平。
Circulation. 2019 Apr 16;139(16):1900-1912. doi: 10.1161/CIRCULATIONAHA.118.037454.
9
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.2016-2018 年 T1D 交换计划中 1 型糖尿病管理状况和结果。
Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089/dia.2018.0384. Epub 2019 Jan 18.
10
10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123. doi: 10.2337/dc19-S010.